Its a small world, page-18

I wonder where we are at with our so called cancer vaccine. Seems this was a slightly different approach to similar issue?? I'm no scientist but maybe this approach is different? And maybe more adaptable. Especially to solid tumors? It seems the Car-t method, while having impressive results , is still considered a last ditch effort after other multiple proven therapies have failed. Seems to have potentially serious side effects and risks. Not sure if our vaccine approach has better safety? I was thinking that if I understand the info our previous approach means we dont even have to harvest, engineer and re introduce patient's own t cells, but I'm probably wrong there. If that were the case though this would have massive cost benefits. I guess the antigens need to be specific to targetted cancer cells.

https://*********.com.au/phylogica-peptide-technology-development-cancer-vaccine/